Hummsa Biotech - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2022, Hummsa Biotech operates in Health Tech offering a pipeline of oral, small-molecule therapies aimed at reshaping the management of metabolic and age-related diseases. The company focus...
Funding stage:
Pre-Seed
Last funding:
31/05/2024
Total funding:
$314.77K+
Investors
Employee count:
2
Last 90d
2
Last 90d
Hummsa Biotech: Funding Highlights
Funding highlights of Hummsa Biotech and a snapshot of its key metrics.
Total Funding$314.77K+
Current StageEarly Stage
Total Round(s)2
Funding Rounds
FAQs on Funding of Hummsa Biotech
Health Tech Funded Hummsa Biotech has raised a total funding of $314.77K dollars as of 01 June 2024 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of Hummsa Biotech here...
Hummsa Biotech has raised a total of $314.77K dollars across 2 funding rounds and the last round was raised on 01 June 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links